Compare SUVEN LIFE with Piramal Healthcare - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFESCIENCES vs PIRAMAL ENTERPRISES - Comparison Results

PIRAMAL ENTERPRISES 
   Change

Piramal Enterprises has a presence in custom manufacturing, critical care OTC and financial services. To give a boost to its custom manufacturing operations, the company had acquired Avecia Pharmaceuticals, UK in 2005 and Pfizer's Morpeth facility in... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFESCIENCES PIRAMAL ENTERPRISES SUVEN LIFESCIENCES/
PIRAMAL ENTERPRISES
 
P/E (TTM) x 4.1 17.0 24.2% View Chart
P/BV x 0.6 1.2 51.9% View Chart
Dividend Yield % 3.8 2.0 190.9%  

Financials

 SUVEN LIFESCIENCES   PIRAMAL ENTERPRISES
EQUITY SHARE DATA
    SUVEN LIFESCIENCES
Mar-19
PIRAMAL ENTERPRISES
Mar-19
SUVEN LIFESCIENCES/
PIRAMAL ENTERPRISES
5-Yr Chart
Click to enlarge
High Rs3383,303 10.2%   
Low Rs1691,797 9.4%   
Sales per share (Unadj.) Rs52.1716.5 7.3%  
Earnings per share (Unadj.) Rs6.879.7 8.6%  
Cash flow per share (Unadj.) Rs8.6107.9 7.9%  
Dividends per share (Unadj.) Rs1.5028.00 5.4%  
Dividend yield (eoy) %0.61.1 53.9%  
Book value per share (Unadj.) Rs65.31,477.5 4.4%  
Shares outstanding (eoy) m127.28184.45 69.0%   
Bonus/Rights/Conversions -IS-  
Price / Sales ratio x4.93.6 136.7%   
Avg P/E ratio x37.132.0 116.0%  
P/CF ratio (eoy) x29.623.6 125.2%  
Price / Book Value ratio x3.91.7 225.0%  
Dividend payout %22.035.1 62.5%   
Avg Mkt Cap Rs m32,272470,292 6.9%   
No. of employees `0001.17.8 13.8%   
Total wages/salary Rs m66122,504 2.9%   
Avg. sales/employee Rs Th6,132.216,899.4 36.3%   
Avg. wages/employee Rs Th611.12,877.7 21.2%   
Avg. net profit/employee Rs Th803.51,879.9 42.7%   
INCOME DATA
Net Sales Rs m6,635132,153 5.0%  
Other income Rs m2423,128 7.7%   
Total revenues Rs m6,877135,281 5.1%   
Gross profit Rs m1,60466,290 2.4%  
Depreciation Rs m2215,202 4.3%   
Interest Rs m3844,097 0.1%   
Profit before tax Rs m1,58720,119 7.9%   
Minority Interest Rs m03,194 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m7188,611 8.3%   
Profit after tax Rs m86914,701 5.9%  
Gross profit margin %24.250.2 48.2%  
Effective tax rate %45.242.8 105.7%   
Net profit margin %13.111.1 117.8%  
BALANCE SHEET DATA
Current assets Rs m6,232122,742 5.1%   
Current liabilities Rs m1,490310,810 0.5%   
Net working cap to sales %71.5-142.3 -50.2%  
Current ratio x4.20.4 1,059.1%  
Inventory Days Days8623 374.7%  
Debtors Days Days8339 212.7%  
Net fixed assets Rs m4,043116,904 3.5%   
Share capital Rs m127369 34.5%   
"Free" reserves Rs m8,183272,161 3.0%   
Net worth Rs m8,310272,530 3.0%   
Long term debt Rs m18270,196 0.0%   
Total assets Rs m10,389856,261 1.2%  
Interest coverage x43.11.5 2,960.1%   
Debt to equity ratio x01.0 0.2%  
Sales to assets ratio x0.60.2 413.8%   
Return on assets %8.76.9 127.2%  
Return on equity %10.55.4 194.0%  
Return on capital %19.512.4 157.1%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m5,62215,200 37.0%   
Fx outflow Rs m1,7994,889 36.8%   
Net fx Rs m3,82210,312 37.1%   
CASH FLOW
From Operations Rs m356-115,975 -0.3%  
From Investments Rs m-279-8,265 3.4%  
From Financial Activity Rs m-225107,525 -0.2%  
Net Cashflow Rs m-148-16,650 0.9%  

Share Holding

Indian Promoters % 63.4 52.9 119.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 4.0 -  
FIIs % 0.0 26.6 -  
ADR/GDR % 0.0 0.0 -  
Free float % 36.5 16.5 221.2%  
Shareholders   37,287 93,274 40.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFESCIENCES With:   TORRENT PHARMA  NATCO PHARMA  AJANTA PHARMA  SANOFI INDIA  ALEMBIC PHARMA  

Compare SUVEN LIFESCIENCES With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 466 Points Higher; Energy, Auto and Realty Stocks Rally(Closing)

Indian share markets extended gains as the session progressed and ended on a strong note, driven by automobile stocks and index heavyweight Reliance Industries.

Related Views on News

PIRAMAL ENTERPRISES Announces Quarterly Results (3QFY20); Net Profit Up 11.7% (Quarterly Result Update)

Feb 5, 2020 | Updated on Feb 5, 2020

For the quarter ended December 2019, PIRAMAL ENTERPRISES has posted a net profit of Rs 6 bn (up 11.7% YoY). Sales on the other hand came in at Rs 38 bn (up 9.1% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

PIRAMAL ENTERPRISES Announces Quarterly Results (2QFY20); Net Profit Up 16.5% (Quarterly Result Update)

Oct 25, 2019 | Updated on Oct 25, 2019

For the quarter ended September 2019, PIRAMAL ENTERPRISES has posted a net profit of Rs 6 bn (up 16.5% YoY). Sales on the other hand came in at Rs 36 bn (up 14.6% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

SUVEN LIFESCIENCES Announces Quarterly Results (1QFY20); Net Profit Up 47.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 572 m (up 47.2% YoY). Sales on the other hand came in at Rs 2 bn (up 3.8% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

PIRAMAL ENTERPRISES Announces Quarterly Results (1QFY20); Net Profit Up 390.0% (Quarterly Result Update)

Aug 1, 2019 | Updated on Aug 1, 2019

For the quarter ended June 2019, PIRAMAL ENTERPRISES has posted a net profit of Rs 4 bn (up 390.0% YoY). Sales on the other hand came in at Rs 35 bn (up 20.8% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

SUVEN LIFESCIENCES 2018-19 Annual Report Analysis (Annual Result Update)

Jul 22, 2019 | Updated on Jul 22, 2019

Here's an analysis of the annual report of SUVEN LIFESCIENCES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUVEN LIFESCIENCES. Also includes updates on the valuation of SUVEN LIFESCIENCES.

More Views on News

Most Popular

How to Find the Best Stocks for Day Trading - 1(Fast Profits Daily)

Jul 2, 2020

In the first of two videos, I'll show you how to identify the best stocks for intraday trading.

Be Prepared to Profit from the Coming Crash in Oil Prices(Fast Profits Daily)

Jun 25, 2020

The stability in crude oil prices will not last much longer. Be ready to make fast profits when the time comes to short crude.

Tata Motors Tripled in 18 Months but You Can Do Even Better. Here's How...(Profit Hunter)

Jun 24, 2020

Rahul is ready for a repeat of his famous 2008 Tata Motors call.

Two Agri Stocks Are Likely to Outperform Even in this Market(Profit Hunter)

Jul 2, 2020

Why we have recommended two agriculture stocks for our Hidden Treasure subscribers. Read on...

More

India's #1 Trader
Reveals His Secrets

The Secret to Increasing Your Trading Profits Today
Get this Special Report, The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFESCIENCES SHARE PRICE


Jul 6, 2020 (Close)

TRACK SUVEN LIFESCIENCES

  • Track your investment in SUVEN LIFESCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SUVEN LIFESCIENCES

SUVEN LIFESCIENCES 8-QTR ANALYSIS

COMPARE SUVEN LIFESCIENCES WITH

MARKET STATS